229 related articles for article (PubMed ID: 26359501)
1. Deletion of MLIP (muscle-enriched A-type lamin-interacting protein) leads to cardiac hyperactivation of Akt/mammalian target of rapamycin (mTOR) and impaired cardiac adaptation.
Cattin ME; Wang J; Weldrick JJ; Roeske CL; Mak E; Thorn SL; DaSilva JN; Wang Y; Lusis AJ; Burgon PG
J Biol Chem; 2015 Oct; 290(44):26699-714. PubMed ID: 26359501
[TBL] [Abstract][Full Text] [Related]
2. HTR2A promotes the development of cardiac hypertrophy by activating PI3K-PDK1-AKT-mTOR signaling.
Gao W; Guo N; Zhao S; Chen Z; Zhang W; Yan F; Liao H; Chi K
Cell Stress Chaperones; 2020 Nov; 25(6):899-908. PubMed ID: 32519137
[TBL] [Abstract][Full Text] [Related]
3. Focal adhesion kinase governs cardiac concentric hypertrophic growth by activating the AKT and mTOR pathways.
Clemente CF; Xavier-Neto J; Dalla Costa AP; Consonni SR; Antunes JE; Rocco SA; Pereira MB; Judice CC; Strauss B; Joazeiro PP; Matos-Souza JR; Franchini KG
J Mol Cell Cardiol; 2012 Feb; 52(2):493-501. PubMed ID: 22056317
[TBL] [Abstract][Full Text] [Related]
4. Akt and MAPK signaling mediate pregnancy-induced cardiac adaptation.
Chung E; Yeung F; Leinwand LA
J Appl Physiol (1985); 2012 May; 112(9):1564-75. PubMed ID: 22345431
[TBL] [Abstract][Full Text] [Related]
5. Carboxypeptidase A4 promotes cardiomyocyte hypertrophy through activating PI3K-AKT-mTOR signaling.
Gao W; Guo N; Zhao S; Chen Z; Zhang W; Yan F; Liao H; Chi K
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32347291
[TBL] [Abstract][Full Text] [Related]
6. Cardiomyocyte-enriched protein CIP protects against pathophysiological stresses and regulates cardiac homeostasis.
Huang ZP; Kataoka M; Chen J; Wu G; Ding J; Nie M; Lin Z; Liu J; Hu X; Ma L; Zhou B; Wakimoto H; Zeng C; Kyselovic J; Deng ZL; Seidman CE; Seidman JG; Pu WT; Wang DZ
J Clin Invest; 2015 Nov; 125(11):4122-34. PubMed ID: 26436652
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin prevents thyroid hormone-induced cardiac hypertrophy.
Kuzman JA; O'Connell TD; Gerdes AM
Endocrinology; 2007 Jul; 148(7):3477-84. PubMed ID: 17395699
[TBL] [Abstract][Full Text] [Related]
8. KLF15 protects against isoproterenol-induced cardiac hypertrophy via regulation of cell death and inhibition of Akt/mTOR signaling.
Gao L; Guo Y; Liu X; Shang D; Du Y
Biochem Biophys Res Commun; 2017 May; 487(1):22-27. PubMed ID: 28336438
[TBL] [Abstract][Full Text] [Related]
9. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy.
Kemi OJ; Ceci M; Wisloff U; Grimaldi S; Gallo P; Smith GL; Condorelli G; Ellingsen O
J Cell Physiol; 2008 Feb; 214(2):316-21. PubMed ID: 17941081
[TBL] [Abstract][Full Text] [Related]
10. Pathological hypertrophy amelioration by PRAS40-mediated inhibition of mTORC1.
Völkers M; Toko H; Doroudgar S; Din S; Quijada P; Joyo AY; Ornelas L; Joyo E; Thuerauf DJ; Konstandin MH; Gude N; Glembotski CC; Sussman MA
Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12661-6. PubMed ID: 23842089
[TBL] [Abstract][Full Text] [Related]
11. Expression of murine muscle-enriched A-type lamin-interacting protein (MLIP) is regulated by tissue-specific alternative transcription start sites.
Cattin ME; Deeke SA; Dick SA; Verret-Borsos ZJA; Tennakoon G; Gupta R; Mak E; Roeske CL; Weldrick JJ; Megeney LA; Burgon PG
J Biol Chem; 2018 Dec; 293(51):19761-19770. PubMed ID: 30389785
[TBL] [Abstract][Full Text] [Related]
12. Cardiac Stim1 Silencing Impairs Adaptive Hypertrophy and Promotes Heart Failure Through Inactivation of mTORC2/Akt Signaling.
Bénard L; Oh JG; Cacheux M; Lee A; Nonnenmacher M; Matasic DS; Kohlbrenner E; Kho C; Pavoine C; Hajjar RJ; Hulot JS
Circulation; 2016 Apr; 133(15):1458-71; discussion 1471. PubMed ID: 26936863
[TBL] [Abstract][Full Text] [Related]
13. Endothelial Leptin Receptor Deletion Promotes Cardiac Autophagy and Angiogenesis Following Pressure Overload by Suppressing Akt/mTOR Signaling.
Gogiraju R; Hubert A; Fahrer J; Straub BK; Brandt M; Wenzel P; Münzel T; Konstantinides S; Hasenfuss G; Schäfer K
Circ Heart Fail; 2019 Jan; 12(1):e005622. PubMed ID: 30621510
[TBL] [Abstract][Full Text] [Related]
14. Compensation of the AKT signaling by ERK signaling in transgenic mice hearts overexpressing TRIM72.
Ham YM; Mahoney SJ
Exp Cell Res; 2013 Jun; 319(10):1451-62. PubMed ID: 23567182
[TBL] [Abstract][Full Text] [Related]
15. PKD deletion promotes autophagy and inhibits hypertrophy in cardiomyocyte.
Zhao D; Gao Y; Wang W; Pei H; Xu C; Zhao Z
Exp Cell Res; 2020 Jan; 386(2):111742. PubMed ID: 31759056
[TBL] [Abstract][Full Text] [Related]
16. Effect of adiponectin on cardiac β-catenin signaling pathway under angiotensin II infusion.
Fujishima Y; Maeda N; Matsuda K; Komura N; Hirata A; Mori T; Sekimoto R; Tsushima Y; Nishizawa H; Funahashi T; Shimomura I
Biochem Biophys Res Commun; 2014 Feb; 444(2):224-9. PubMed ID: 24462873
[TBL] [Abstract][Full Text] [Related]
17. CD38 promotes angiotensin II-induced cardiac hypertrophy.
Guan XH; Hong X; Zhao N; Liu XH; Xiao YF; Chen TT; Deng LB; Wang XL; Wang JB; Ji GJ; Fu M; Deng KY; Xin HB
J Cell Mol Med; 2017 Aug; 21(8):1492-1502. PubMed ID: 28296029
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel muscle A-type lamin-interacting protein (MLIP).
Ahmady E; Deeke SA; Rabaa S; Kouri L; Kenney L; Stewart AF; Burgon PG
J Biol Chem; 2011 Jun; 286(22):19702-13. PubMed ID: 21498514
[TBL] [Abstract][Full Text] [Related]
19. miR-29a promotes pathological cardiac hypertrophy by targeting the PTEN/AKT/mTOR signalling pathway and suppressing autophagy.
Shi JY; Chen C; Xu X; Lu Q
Acta Physiol (Oxf); 2019 Oct; 227(2):e13323. PubMed ID: 31162869
[TBL] [Abstract][Full Text] [Related]
20. DJ-1 activates autophagy in the repression of cardiac hypertrophy.
Xue R; Jiang J; Dong B; Tan W; Sun Y; Zhao J; Chen Y; Dong Y; Liu C
Arch Biochem Biophys; 2017 Nov; 633():124-132. PubMed ID: 28941803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
